Defective B cell ontogeny and immune response are partially reversed in aging human complement receptor 2 (CR2, CD21) transgenic mice

被引：0
|
作者：
Kulik, Liudmila
Holers, V. Michael
Marchbank, Kevin J.
机构：
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80202 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80202 USA
[3] Univ Cardiff Wales, Sch Med, Dept Med Biochem & Immunol, Cardiff, Wales
来源：
MOLECULAR IMMUNOLOGY | 2007年 / 44卷 / 1-3期
关键词：
D O I：
10.1016/j.molimm.2006.07.125
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
120
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain
    Hoefer, Melanie M.
    Aichem, Annette
    Knight, Andrew M.
    Illges, Harald
    MOLECULAR IMMUNOLOGY, 2008, 45 (08) : 2127 - 2137
  • [32] Changes in chromatin accessibility across the complement receptor 2 (CR2/CD21) gene promoter occurs during different stages of B cell development
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162
  • [33] Transcriptional effects of a lupus-associated polymorphism in the 5′ untranslated region (UTR) of human complement receptor 2 (CR2/CD21)
    Cruickshank, Mark N.
    Karimi, Mahdad
    Mason, Rhonda L.
    Fenwick, Emily
    Mercer, Tim
    Tsao, Betty P.
    Boackle, Susan A.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2012, 52 (3-4) : 165 - 173
  • [34] ANALYSIS OF EPITOPE EXPRESSION AND THE FUNCTIONAL REPERTOIRE OF RECOMBINANT COMPLEMENT RECEPTOR-2 (CR2/CD21) IN MOUSE AND HUMAN-CELLS
    CAREL, JC
    FRAZIER, B
    LEY, TJ
    HOLERS, VM
    JOURNAL OF IMMUNOLOGY, 1989, 143 (03): : 923 - 930
  • [35] Complement receptor CR2/CD21 proximal promoter activity is critically dependent upon a cell type specific repressor.
    Ulgiati, D
    Holers, VM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S203 - S203
  • [36] Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)
    Hess, MW
    Schwendinger, MG
    Eskelinen, EL
    Pfaller, K
    Pavelka, M
    Dierich, MP
    Prodinger, WM
    BLOOD, 2000, 95 (08) : 2617 - 2623
  • [37] Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
    Masilamani, M
    von Kempis, J
    Illges, H
    RHEUMATOLOGY, 2004, 43 (02) : 186 - 190
  • [38] The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras
    Johnson, AA
    Rosengard, AM
    Skjodt, K
    Ahearn, JM
    Leslie, RGQ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (12) : 3837 - 3844
  • [39] Role of complement receptors type 2 (CR2/CD21) and 1 (CR1/CD35) in murine lupus
    Holers, VM
    Boackle, SA
    Jiang, N
    Jeong, CH
    Molina, H
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 355 - 355
  • [40] The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2)
    Mongini, PKA
    Vilensky, MA
    Highet, PF
    Inman, JK
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 3782 - 3791
12345